Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...